NuVasive Stock News

Prominent joint reconstruction devices manufacturers across the globe include Stryker, ConforMIS, Smith & Nephew, NuVasive, Medtronic, Globus Medical, Medacta, Zimmer Biomet, DJO Global, MicroPort Scientific Corporation, and Waldemar LINK. Prominent joint reconstruction devices manufacturers across the globe include Stryker, ConforMIS, Smith & Nephew, NuVasive, Medtronic, Globus Medical, Medacta, Zimmer Biomet, DJO Global, MicroPort Scientific Corporation, and Waldemar LINK.

A Global Orthopaedic Surgical Robots Market, which is an in-depth study providing complete analysis of the industry for the period 2021 to 2027. It provides complete overview of Global Orthopaedic Surgical Robots industry considering all the major industry trends, market

In the superior Orthotic Devices market report, the whole and crystal clear outline of the Orthotic Devices market is penned down which is valuable for many businesses. The info covered in this consistent report helps businesses know how patents, licensing

First Hawaiian Bank lessened its holdings in shares of NuVasive, Inc. (NASDAQ:NUVA) by 17.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,465 shares of the medical device companys stock after selling 1,385 shares during the period. First Hawaiian []

IFP Advisors Inc trimmed its position in NuVasive, Inc. (NASDAQ:NUVA) by 32.2% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,427 shares of the medical device companys stock after selling 3,055 shares during the period. IFP Advisors Incs holdings in NuVasive were []

The Spinal Posterior Fixation System Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts

The Spinal Trauma Devices market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market

SAN DIEGO, Nov. 18, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that NuVasive CEO J. Christopher Barry will virtually

Y Intercept Hong Kong Ltd acquired a new stake in shares of NuVasive, Inc. (NASDAQ:NUVA) during the second quarter, HoldingsChannel reports. The fund acquired 3,530 shares of the medical device companys stock, valued at approximately $239,000. A number of other hedge funds also recently modified their holdings of NUVA. Point72 Asset Management L.P. purchased a []

The Spinal Devices market is a comprehensive market research report which provides market analysis with a historical & futuristic perspective for the following parameters; market size, revenue, demand, and supply data (as applicable). The report offers a detailed market analysis

NuVasive's (NUVA) declining spine implant business might get a boost if its consolidation with Globus Medical takes place.

NuVasive's (NUVA) declining spine implant business might get a boost if its consolidation with Globus Medical takes place.

Shares of NuVasive, Inc. (NASDAQ:NUVA) have been assigned a consensus recommendation of Hold from the sixteen ratings firms that are covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and eight have given a buy recommendation to the company. The average []

UBS Asset Management Americas Inc. raised its position in NuVasive, Inc. (NASDAQ:NUVA) by 2.3% during the second quarter, Holdings Channel reports. The firm owned 58,635 shares of the medical device companys stock after buying an additional 1,326 shares during the quarter. UBS Asset Management Americas Inc.s holdings in NuVasive were worth $3,974,000 at the end []